Reversible nephrotoxicity after overdose of colloidal bismuth subcitrate

Pediatric Nephrology

Volumn 16, Issue 6, 2001, Pages 510-514

  Işlek, Ismail ^a   Uysal, Serap ^a   Gök, Faysal ^b   Dündaröz, Ruşen ^b   Küçüködük, Şükrü ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Acute renal failure; Bismuth subcitrate overdose; Child; Peritoneal dialysis

Indexed keywords

BISMUTH CITRATE; CREATININE; NITROGEN; UREA;

ACUTE KIDNEY FAILURE; ARTICLE; CASE REPORT; CHILD; CHILDHOOD; CONCENTRATION (PARAMETERS); CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG OVERDOSE; DRUG URINE LEVEL; DRUG USE; FLUID THERAPY; HOSPITAL ADMISSION; HUMAN; INGESTION; MALE; NEPHROTOXICITY; OLIGURIA; PERITONEAL DIALYSIS; PILL; PRIORITY JOURNAL; PROGNOSIS; STOMACH LAVAGE; TABLET; TIME; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; UREMIA; URINE VOLUME;

ANTI-ULCER AGENTS; BISMUTH; BLOOD UREA NITROGEN; CHILD, PRESCHOOL; COLLOIDS; CREATININE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; ORGANOMETALLIC COMPOUNDS; OVERDOSE; PERITONEAL DIALYSIS;

EID: 0034991742     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670100584     Document Type: Article

References (27)

1. Bismuth therapy in gastrointestinal diseases
2. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease
3. Pharmacology of bismuth containing compounds
4. Bismuth subsalicylate: History, chemistry, and safety
5. Pharmacokinetics and toxicity of bismuth compounds
6. Agents for control of gastric acidity and treatment of peptic ulcers
7. Tripotassium dicitrato bismuthate: Absorption and urinary excretion of bismuth in patients with normal and impaired renal function
8. The safety profile of De-Nol
9. Reversible toxicity in poisoning with colloidal bismuth subcitrate
10. Acute renal failure after colloidal bismuth subcitrate overdose
11. Acute renal failure after overdose of colloidal bismuth subcitrate
12. Significant elimination of bismuth by hemodialysis with a new heavy-metal chelating agent
13. Acute renal failure due to overdose of colloidal bismuth
14. Encephalopathies aigues au cours des traitements oraux par les sels de bismuth
15. Bismuth induced encephalopathy caused by tri potassium dicitrato bismuthate in a patient with chronic renal failure
16. Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy
17. Encephalopathy from abuse of bismuth subsalicylate
18. Bismuth salts and neurotoxicity. A randomised, single-blind and controlled study
19. Chronic salicylate toxicity due to consumption of over-the-counter bismuth subsalicylate
20. Fatal salicylate toxicity from bismuth subsalicylate
21. Respiratory difficulty following bismuth subgallate aspiration
22. Bismuth in human serum: Reference interval and concentrations after intake of a therapeutic dose of colloidal bismuth subcitrate
23. Bismuth nephrotoxicity
24. Position statement: Whole bowel irrigation
25. Encephalopathie aux sels insolubles de bismuth
26. Encephalopathia myoclonica convulsiva por bismuto. Utilitad del tratamiento con dimercaprol
27. Myoclonic encephalopathy due to bismuth salts: Treatment with dimereaprol and analysis of CSF transmitters